Clinical Trials Logo

Post-Dural Puncture Headache clinical trials

View clinical trials related to Post-Dural Puncture Headache.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03430531 Terminated - Clinical trials for Post-Dural Puncture Headache

Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Start date: May 31, 2019
Phase: Phase 2
Study type: Interventional

The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).

NCT ID: NCT03112720 Terminated - Clinical trials for Postdural Puncture Headache

Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache

Start date: September 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare a pain block in the midface, versus the traditional, more invasive, therapeutic epidural patch for the treatment of headaches

NCT ID: NCT02984618 Terminated - Clinical trials for Post-Dural Puncture Headache

Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial

Start date: December 1, 2016
Phase: N/A
Study type: Interventional

Introduction: Recently sphenopalatine block emerged as an alternative to epidural blood patch for post dural puncture headache but the investigators do not know if it has significant efficacy when compared to epidural blood patch. Method: randomized trial where patients will randomly receive either sphenopalatine block or epidural blood patch. Pain relief to no pain or low intensity pain will be the main outcome

NCT ID: NCT02962427 Terminated - Headache Clinical Trials

Treatment of Post-dural Puncture Headache in Postpartum Patients: Sphenopalatine Ganglion Block to Epidural Blood Patch.

Start date: November 2016
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to compare the effectiveness of a sphenopalatine ganglion block to an epidural blood patch for post-dural puncture headache relief in randomized postpartum parturients over a 48 hour period.

NCT ID: NCT02827058 Terminated - Clinical trials for Post-Dural Puncture Headache

The Influence of Needle Diameter on Post Dural Puncture Headache

Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether injection needle pen point type 'PP Gauge 25' should be recommended as a primary choice of needle (in stead of 'PP Gauge 27') for healthy pregnant women who at delivery (vaginal or cesarean section) get spinal anesthesia.

NCT ID: NCT02813655 Terminated - Clinical trials for Post-dural Puncture Headache

Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)

ESYBRECHE
Start date: October 2016
Phase: Phase 2
Study type: Interventional

The aim of the study is to assess the efficacy and safety of Synacthène® versus placebo in the treatment of post-dural puncture syndrome in patients receiving epidural analgesia, spinal analgesia, or combined spinal-epidural analgesia for labour.

NCT ID: NCT02427009 Terminated - Clinical trials for Post-Dural Puncture Headache

Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache

UpSideDown
Start date: December 2015
Phase: N/A
Study type: Interventional

The main objective of this study is to assess the rate of recurrence of headache following a first blood patch where patients will be positioned in the prone position for an hour after each blood patch needed during this study.

NCT ID: NCT02365909 Terminated - Clinical trials for Postdural Puncture Headache

Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)

PDPH
Start date: June 29, 2015
Phase: Early Phase 1
Study type: Interventional

Postdural puncture headaches (PDPH) are a consequence of spinal and epidural anesthesia in approximately 1% of cases when performed in obstetric patients. The gold standard treatment for a PDPH is currently an epidural blood patch (EBP), which involves placing a needle back into the epidural space of the neuraxium and then injecting 20 ml of the patient's own blood through the needle and into the epidural space to form a clot over the insult in the tissue layer that causes the headaches. The investigators want to test the efficacy of using a less invasive procedure, called a sphenopalatine block (SPGB), for treatment of PDPH. SPGB has been used for many years in the treatment of migraines and cluster headaches, and there are several case reports of its use to successfully treat PDPH as well. SPGB simply involves applying a local anesthetic to the mucosa in the back of each nostril to numb the nerves that cause the headache. The investigators hope that the SPGB will reduce the number of PDPH patients that require and EBP.